Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 3
2012 2
2013 5
2014 9
2015 8
2016 17
2017 8
2018 8
2019 9
2020 21
2021 25
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

105 results
Results by year
Filters applied: . Clear all
Page 1
Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma.
Kondrashova O, Nguyen M, Shield-Artin K, Tinker AV, Teng NNH, Harrell MI, Kuiper MJ, Ho GY, Barker H, Jasin M, Prakash R, Kass EM, Sullivan MR, Brunette GJ, Bernstein KA, Coleman RL, Floquet A, Friedlander M, Kichenadasse G, O'Malley DM, Oza A, Sun J, Robillard L, Maloney L, Bowtell D, Giordano H, Wakefield MJ, Kaufmann SH, Simmons AD, Harding TC, Raponi M, McNeish IA, Swisher EM, Lin KK, Scott CL; AOCS Study Group. Kondrashova O, et al. Among authors: kichenadasse g. Cancer Discov. 2017 Sep;7(9):984-998. doi: 10.1158/2159-8290.CD-17-0419. Epub 2017 Jun 6. Cancer Discov. 2017. PMID: 28588062 Free PMC article. Clinical Trial.
Nuances to precision dosing strategies of targeted cancer medicines.
Hopkins AM, Menz BD, Wiese MD, Kichenadasse G, Gurney H, McKinnon RA, Rowland A, Sorich MJ. Hopkins AM, et al. Among authors: kichenadasse g. Pharmacol Res Perspect. 2020 Aug;8(4):e00625. doi: 10.1002/prp2.625. Pharmacol Res Perspect. 2020. PMID: 32662214 Free PMC article. Review.
Germline PALB2 Variants and PARP Inhibitors in Endometrial Cancer.
Cilento MA, Poplawski NK, Paramasivam S, Thomas DM, Kichenadasse G. Cilento MA, et al. Among authors: kichenadasse g. J Natl Compr Canc Netw. 2021 Nov;19(11):1212-1217. doi: 10.6004/jnccn.2021.7067. J Natl Compr Canc Netw. 2021. PMID: 34781271
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian small cell cancers.
Reed NS, Pautier P, Åvall-Lundqvist E, Choi CH, du Bois A, Friedlander M, Fyles A, Kichenadasse G, Provencher DM, Ray-Coquard I. Reed NS, et al. Among authors: kichenadasse g. Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S30-4. doi: 10.1097/IGC.0000000000000293. Int J Gynecol Cancer. 2014. PMID: 25341577 Review.
Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposure.
Rowland A, van Dyk M, Mangoni AA, Miners JO, McKinnon RA, Wiese MD, Rowland A, Kichenadasse G, Gurney H, Sorich MJ. Rowland A, et al. Among authors: kichenadasse g. Expert Opin Drug Metab Toxicol. 2017 Jan;13(1):31-49. doi: 10.1080/17425255.2016.1229303. Epub 2016 Sep 1. Expert Opin Drug Metab Toxicol. 2017. PMID: 27561659 Review.
105 results